Michael Hummel
Impact in
- Pathology and Forensic Medicine top 0.02%
- Lymphoma Diagnosis and Treatment
- Oncology top 0.1%
- Viral-associated cancers and disorders
Papers in
-
- Lymphoma Diagnosis and Treatment 160
- Oncology 170
- Viral-associated cancers and disorders 72
- CAR-T cell therapy research 27
- Co-authors
- Harald SteinIoannis AnagnostopoulosH. SteinEzio BonifacioHans‐Dieter FossAnette‐Gabriele ZieglerI. AnagnostopoulosGudrun Demel
- Journals
- Blood (53 papers)The Journal of Pathology (24 papers)Annals of Oncology (10 papers)Journal of Clinical Oncology (8 papers)Diabetologia (8 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Michael Hummel
440 papers receiving 18.1k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Pathology and Forensic Medicine 8.4k
- Oncology 7.6k
- Genetics 2.7k
- Immunology 4.0k
- Dermatology 1.3k
Countries citing papers authored by Michael Hummel
This map shows the geographic impact of Michael Hummel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hummel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hummel more than expected).
Fields of papers citing papers by Michael Hummel
This network shows the impact of papers produced by Michael Hummel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hummel. The network helps show where Michael Hummel may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Hummel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 8 | |
| 8 | 2021 | 14 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 23 | |
| 11 | 2021 | 0 | |
| 12 | 2019 | 32 | |
| 13 | 2019 | 2 | |
| 14 | 2013 | 112 | |
| 15 | 2010 | 25 | |
| 16 | Conserved oncogenic module activation patterns (COMAPS) identify biologically homogeneous groups of diffuse large B-cell lymphomas and clearly define Burkitt lymphoma | 2008 | 2 |
| 17 | 2004 | 29 | |
| 18 | Monotherapy with the anti-CD20 antibody rituximab (ritux) in patients with post-transplant lympho-proliferative disease (PTLD). Results of a multicentre phase II study. | 2002 | 2 |
| 19 | 1997 | 367 | |
| 20 | 1997 | 33 |
About Michael Hummel
Michael Hummel is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Gastroenterology and Immunology, having authored 461 papers that have together received 18.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (160 papers), Viral-associated cancers and disorders (72 papers), Chronic Lymphocytic Leukemia Research (55 papers), Diabetes and associated disorders (35 papers), Cancer Genomics and Diagnostics (31 papers), Diabetes Management and Research (30 papers), Monoclonal and Polyclonal Antibodies Research (29 papers) and CAR-T cell therapy research (27 papers). The work is most often cited by research in Pathology and Forensic Medicine (8.4k citations), Oncology (7.6k citations), Genetics (2.7k citations), Immunology (4.0k citations) and Dermatology (1.3k citations). Michael Hummel has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Harald Stein, Harald Stein, Ioannis Anagnostopoulos, H. Stein, Ezio Bonifacio, Hans‐Dieter Foss, Anette‐Gabriele Ziegler, I. Anagnostopoulos, Gudrun Demel and Dido Lenze. Their work appears in journals such as Blood, The Journal of Pathology, Annals of Oncology, Journal of Clinical Oncology and Diabetologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.